Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.09 USD | +7.63% | +15.16% | +56.01% |
May. 14 | Stephens Initiates Nurix Therapeutics With Overweight Rating, $20 Price Target | MT |
Apr. 12 | Sector Update: Health Care Stocks Steady Pre-Bell Friday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.01% | 887M | |
+7.53% | 111B | |
+11.40% | 106B | |
-12.49% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.52% | 16.81B | |
+37.95% | 12.54B | |
-24.27% | 8.09B |
- Stock Market
- Equities
- NRIX Stock
- News Nurix Therapeutics, Inc.
- Morgan Stanley Adjusts Nurix Therapeutics' Price Target to $10 From $9, Keeps Equalweight Rating